|
[1]
|
Nalysnyk, L., Rotella, P., Simeone, J.C., et al. (2017) Gaucher Disease Epidemiology and Natural History: A Comprehensive Review of the Literature. Hematology, 22, 65-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zion, Y.C., Pappadopulos, E., Wajnrajch, M., et al. (2016) Re-Thinking Fatigue in Gaucher Disease. Orphanet Journal of Rare Diseases, 29, 1-7.
|
|
[3]
|
商春阳, 陈春雷, 贾敦茂, 等. 戈谢病治疗方式研究进展[J]. 中华普通外科杂志, 2018, 33(5): 442-444.
|
|
[4]
|
Masi, L. and Brandi, M.L. (2015) Gaucher Disease: The Role of the Specialist on Metabolic Bone Diseases. Clinical Cases in Mineral and Bone Metabolism, 12, 165-169. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Casirati, G., Baldini, M., Ulivieri, F.M., et al. (2018) Skeletal Involvement in Type 1 Gaucher Disease: Not Just Bone Mineral Density. Blood Cells, Molecules and Diseases, 68, 148-152. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Marcucci, G., Zimran, A., Bembi, B., et al. (2014) Gaucher Disease and Bone Manifestations. Calcified Tissue International, 95, 477-494. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kaluzna, M., Trzeciak, I., Ziemnicka, K., et al. (2019) Endocrine and Metabolic Disorders in Patients with Gaucher Disease Type 1: A Review. Orphanet Journal of Rare Diseases, 14, 275. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Biegstraaten, M., Cox, T.M., Belmatoug, N., et al. (2016) Management Goals for Type 1 Gaucher Disease: An Expert Consensus Document from the European Working Group on Gaucher Disease. Blood Cells, Molecules and Diseases, 68, 203-208. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, A.C., Bier, L., Overbey, J.R., et al. (2017) Early Manifestations of Type 1 Gaucher Disease in Presymptomatic Children Diagnosed after Parental Carrier Screening. Genetics in Medicine, 19, 652-658. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Giraldo, P., Pérez-López, J., Núňez, R., et al. (2016) Patients with Type 1 Gaucher Disease in Spain: A Cross-Sectional Evaluation of Health Status. Blood Cells, Molecules and Diseases, 56, 23-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hughes, D., Mikosch, P., Belmatoug, N., et al. (2019) Gaucher Disease in Bone: From Pathophysiology to Practice. Journal of Bone and Mineral Research, 34, 996-1013. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Khan, A., Hangartner, T., Weinreb, N.J., et al. (2012) Risk Factors for Fractures and Avascular Osteonecrosis in Type 1 Gaucher Disease: A Study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Journal of Bone and Mineral Research, 27, 1839-1848. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
曹隽, 张学军. 儿童早发性脊柱侧弯的系统治疗[J]. 临床小儿外科杂志, 2021, 20(1): 1-5.
|
|
[14]
|
Revel-Vilk, S., Szer, J., Mehta, A., et al. (2018) How We Manage Gaucher Disease in the Era of Choices. British Journal of Haematology, 182, 467-480. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
中华医学会儿科学分会遗传代谢内分泌学组, 中华医学会儿科学分会血液学组, 中华医学会血液学分会红细胞疾病(贫血)学组. 中国戈谢病诊治专家共识(2015) [J]. 中华儿科杂志, 2015, 53(4): 256-261.
|
|
[16]
|
El-Beshlawy, A., Tylki-Szymanska, A., Vellodi, A., et al. (2017) Long-Term Hematological, Visceral, and Growth Outcomes in Children with Gaucher Disease Type 3 Treated with Imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism, 120, 47-56. [Google Scholar] [CrossRef] [PubMed]
|